Safety and immunogenicity of a mosaic vaccine booster against Omicron and other SARS-CoV-2 variants: a randomized phase 2 trial.
Signal Transduct Target Ther
; 8(1): 20, 2023 01 03.
Article
em En
| MEDLINE
| ID: mdl-36596779
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Vacinas
/
COVID-19
Limite:
Adult
/
Humans
Idioma:
En
Ano de publicação:
2023